Literature DB >> 24078485

Temporal trends in the incidence of osteoporotic fractures.

S N Morin, L M Lix, S R Majumdar, W D Leslie.   

Abstract

Osteoporotic fractures are associated with excess mortality and decreased functional capacity and quality of life. Age-standardized incidence rates of fragility fractures, particularly of the hip and forearm, have been noted to be decreasing in the last decade across many countries with the notable exception of Asia. The causes for the observed changes in fracture risk have not been fully identified but are likely the result of multiple factors, including birth cohort and period effects, increasing obesity, and greater use of anti-osteoporosis medications. Changing rates of fragility fractures would be expected to have an important impact on the burden of osteoporosis.

Entities:  

Mesh:

Year:  2013        PMID: 24078485     DOI: 10.1007/s11914-013-0168-x

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  95 in total

1.  Trends in hospital admissions for fractures of the hip and femur in England, 1989-1990 to 1997-1998.

Authors:  S Balasegaram; A Majeed; H Fitz-Clarence
Journal:  J Public Health Med       Date:  2001-03

2.  Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study.

Authors:  L H Martín Arias; C Treceño; P García-Ortega; J Rodríguez-Paredes; A Escudero; M Sáinz; I Salado; V Velasco; A Carvajal
Journal:  Eur J Clin Pharmacol       Date:  2012-07-21       Impact factor: 2.953

3.  Fracture hospitalizations between years 2000 and 2007 in Switzerland: a trend analysis.

Authors:  K Lippuner; A W Popp; P Schwab; M Gitlin; T Schaufler; C Senn; R Perrelet
Journal:  Osteoporos Int       Date:  2010-12-09       Impact factor: 4.507

4.  Recent trends in hip fracture rates by race/ethnicity among older US adults.

Authors:  Nicole C Wright; Kenneth G Saag; Jeffrey R Curtis; Wilson K Smith; Meredith L Kilgore; Michael A Morrisey; Huifeng Yun; Jie Zhang; Elizabeth S Delzell
Journal:  J Bone Miner Res       Date:  2012-11       Impact factor: 6.741

5.  Incidence of second hip fracture and compliant use of bisphosphonate.

Authors:  Y-K Lee; Y-C Ha; B-H Yoon; K-H Koo
Journal:  Osteoporos Int       Date:  2012-12-18       Impact factor: 4.507

6.  Treatment and survival among elderly Americans with hip fractures: a population-based study.

Authors:  G L Lu-Yao; J A Baron; J A Barrett; E S Fisher
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

7.  The components of excess mortality after hip fracture.

Authors:  J A Kanis; A Oden; O Johnell; C De Laet; B Jonsson; A K Oglesby
Journal:  Bone       Date:  2003-05       Impact factor: 4.398

8.  Continuous decline in incidence of hip fracture: nationwide statistics from Finland between 1970 and 2010.

Authors:  N Korhonen; S Niemi; J Parkkari; H Sievänen; M Palvanen; P Kannus
Journal:  Osteoporos Int       Date:  2012-10-30       Impact factor: 4.507

9.  Epidemiology of proximal humeral fractures in Austria between 1989 and 2008.

Authors:  H P Dimai; A Svedbom; A Fahrleitner-Pammer; T Pieber; H Resch; E Zwettler; H Thaler; M Szivak; K Amrein; F Borgström
Journal:  Osteoporos Int       Date:  2013-04-09       Impact factor: 4.507

10.  Heterogeneity in hip fracture patients: age, functional status, and comorbidity.

Authors:  Joan D Penrod; Ann Litke; William G Hawkes; Jay Magaziner; Kenneth J Koval; John T Doucette; Stacey B Silberzweig; Albert L Siu
Journal:  J Am Geriatr Soc       Date:  2007-03       Impact factor: 5.562

View more
  8 in total

1.  Hip fracture incidence and social deprivation: results from a French ecological study.

Authors:  M -P Petit; J Bryère; M Maravic; F Pallaro; C Marcelli
Journal:  Osteoporos Int       Date:  2017-03-23       Impact factor: 4.507

2.  Comparison of morbidity and mortality of hip and vertebral fragility fractures: Which one has the highest burden?

Authors:  Maroun Rizkallah; Falah Bachour; Mirvat El Khoury; Amer Sebaaly; Boutros Finianos; Rawad El Hage; Ghassan Maalouf
Journal:  Osteoporos Sarcopenia       Date:  2020-08-08

3.  Functional recovery after treatment of extra-articular distal radius fractures in the elderly using the IlluminOss® System (IO-Wrist); a multicenter prospective observational study.

Authors:  Tjebbe Hagenaars; Guido W Van Oijen; W Herbert Roerdink; Paul A Vegt; Jos P A M Vroemen; Michael H J Verhofstad; Esther M M Van Lieshout
Journal:  BMC Musculoskelet Disord       Date:  2016-05-27       Impact factor: 2.362

4.  Use of combination therapy in the treatment of primary osteoporosis: protocol for a network meta-analysis of randomised trials.

Authors:  Shenghan Lou; Houchen Lv; Yuxiang Chen; Licheng Zhang; Peifu Tang
Journal:  BMJ Open       Date:  2016-11-08       Impact factor: 2.692

5.  Graded motor imagery for women at risk for developing type I CRPS following closed treatment of distal radius fractures: a randomized comparative effectiveness trial protocol.

Authors:  Corey McGee; Jennifer Skye; Ann Van Heest
Journal:  BMC Musculoskelet Disord       Date:  2018-06-26       Impact factor: 2.362

6.  Centenarian hip fracture patients: a nationwide population-based cohort study of 507 patients.

Authors:  Mathias Mosfeldt; Christian M Madsen; Jes B Lauritzen; Henrik L Jørgensen
Journal:  Acta Orthop       Date:  2019-04-18       Impact factor: 3.717

7.  Preventing functional loss during immobilization after osteoporotic wrist fractures in elderly patients: a randomized clinical trial.

Authors:  Nadja Schott; Heide Korbus
Journal:  BMC Musculoskelet Disord       Date:  2014-08-30       Impact factor: 2.362

8.  Finger Fractures as an Early Manifestation of Primary Hyperparathyroidism Among Young Patients: A Case Report of a 30-Year-Old Male With Recurrent Osteoporotic Fractures.

Authors:  Akihiko Ozaki; Tetsuya Tanimoto; Eiki Yamagishi; Shunsuke Sato; Manabu Tsukada; Toyoaki Sawano; Claire Leppold; Kenji Tsuda; Takanori Asakura; Masaharu Tsubokura; Shigeaki Kato; Masahiro Kami; Hiromichi Ohira
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.